Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin Neuroprotection and Carotid Endarterectomy
NCT02850081Phase 3Terminated
- Sponsor
- Columbia University
- Start
- Jun 2017
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of ulinastatin in carotid artery stenosis (CAS) (3 arms), sponsored by Columbia University. Primary endpoint: Prevalence of early cognitive dysfunction (eCD) at 30 days. Started Jun 2017; status: terminated.
02
Drugs
ulinastatin
03
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT02850081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850081.